As such, the repressed STING expression secondary to hypermethylation of the STING promoter observed in many high grade primary brain tumors may offer an explanation for their resistance to treatment (Low et al., 2022; Qiu et al., 2022). The gene discussed is STING1; the disease is brain neoplasm.